|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/132 | (2006.01) |
| A61K 31/4412 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 33/24 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/282 | (2006.01) |
| (11) | Number of the document | 1757283 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05745983.6 |
| Date of filing the European patent application | 2005-06-02 | |
| (97) | Date of publication of the European application | 2007-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-17 |
| (46) | Date of publication of the claims translation | 2013-02-25 |
| (86) | Number | PCT/JP2005/010182 |
| Date | 2005-06-02 |
| (87) | Number | WO 2005/120480 |
| Date | 2005-12-22 |
| (30) | Number | Date | Country code |
| 2004171520 | 2004-06-09 | JP |
| (72) |
KOIZUMI, Katsuhisa, JP
UCHIDA, Junji, JP
TAKECHI, Teiji, JP
NUKATSUKA, Mamoru, JP
|
| (73) |
TAIHO PHARMACEUTICAL CO., LTD.,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-0054,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešnavikinio poveikio stipriklis, priešnavikinis agentas ir vėžio gydymo būdas |
| ANTITUMOR EFFECT FORTIFIER, ANTITUMOR AGENT AND METHOD OF THERAPY FOR CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-05-09 | 347.00 EUR |